Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).
Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA; RECORD Trial Group. Avenell A, et al. Among authors: jenkinson dj. J Clin Endocrinol Metab. 2012 Feb;97(2):614-22. doi: 10.1210/jc.2011-1309. Epub 2011 Nov 23. J Clin Endocrinol Metab. 2012. PMID: 22112804 Clinical Trial.
Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients.
Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA; Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group. Andrews PJ, et al. Among authors: jenkinson dj. BMJ. 2011 Mar 17;342:d1542. doi: 10.1136/bmj.d1542. BMJ. 2011. PMID: 21415104 Free article. Clinical Trial.
The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial.
Cuthbertson BH, Rattray J, Campbell MK, Gager M, Roughton S, Smith A, Hull A, Breeman S, Norrie J, Jenkinson D, Hernández R, Johnston M, Wilson E, Waldmann C; PRaCTICaL study group. Cuthbertson BH, et al. BMJ. 2009 Oct 16;339:b3723. doi: 10.1136/bmj.b3723. BMJ. 2009. PMID: 19837741 Free PMC article. Clinical Trial.
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.
Imamura M, Abrams P, Bain C, Buckley B, Cardozo L, Cody J, Cook J, Eustice S, Glazener C, Grant A, Hay-Smith J, Hislop J, Jenkinson D, Kilonzo M, Nabi G, N'Dow J, Pickard R, Ternent L, Wallace S, Wardle J, Zhu S, Vale L. Imamura M, et al. Health Technol Assess. 2010 Aug;14(40):1-188, iii-iv. doi: 10.3310/hta14400. Health Technol Assess. 2010. PMID: 20738930 Free article. Review.
Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.
Hislop J, Quayyum Z, Elders A, Fraser C, Jenkinson D, Mowatt G, Sharma P, Vale L, Petty R. Hislop J, et al. Health Technol Assess. 2011 Jun;15(25):1-178. doi: 10.3310/hta15250. Health Technol Assess. 2011. PMID: 21689502 Free PMC article. Review.
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Ramsay C, et al. Health Technol Assess. 2012;16(41):1-313. doi: 10.3310/hta16410. Health Technol Assess. 2012. PMID: 23127367 Free PMC article. Review.
Systematic review of escalated imatinib doses compared with sunitinib or best supportive care, for the treatment of people with unresectable/metastatic gastrointestinal stromal tumours whose disease has progressed on the standard imatinib dose.
Hislop J, Mowatt G, Sharma P, Fraser C, Elders A, Jenkinson D, Vale L, Petty R. Hislop J, et al. J Gastrointest Cancer. 2012 Jun;43(2):168-76. doi: 10.1007/s12029-011-9325-6. J Gastrointest Cancer. 2012. PMID: 21971958 Free PMC article. Review.
39 results